Atovaquone And Proguanil Hydrochloride Tablet, Film Coated
Product Images NDC 63187-879

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hydrochloride (NDC 63187-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-879-24 (Adult Label)

Label for Atovaquone 250 mg and Proguanil HCl 100 mg tablets, film-coated, oral dosage form, in a package of 24 tablets. Manufactured by Glenmark Pharmaceuticals Ltd., India. The label includes the ProficientRx logo, NDC 63187-879-24, and notes the tablet's physical description and storage instructions.*

FDA Label Image

Atovaquone (Atovaquone)

Chemical structure diagram of the active ingredient Atovaquone, shown as a molecular formula with labeled carbon rings, oxygen, hydroxyl group, and chlorine atom.*

FDA Label Image

Logo (Logo)

FDA Label Image

Proguanil (Proguanil)

Chemical structure diagram of Atovaquone and Proguanil Hydrochloride showing the molecular arrangement including a chlorinated aromatic ring and associated functional groups with a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.